BRITTANY ZEIGLER: Open Payments
NPI 1558996470 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 62 payments from 23 companies in 2025. Trend: 2023 $1,808 · 2024 $1,422 · 2025 $1,338
Food & beverage: $1,238Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $221 |
| Janssen Biotech, Inc. | 7 | $201 |
| ABBVIE INC. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Incyte Corporation | 4 | $84 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| PFIZER INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Celgene Corporation | 3 | $49 |
Products named: DARZALEX, KEYTRUDA, LYNPARZA, RYBREVANT, IMBRUVICA, REBLOZYL, JAKAFI, FOTIVDA.
Industry payments across OH — which companies pay providers there.
